Mircera 100mcg Injection
By Mircera
Rx
1ml Injection in a Prefilled syringe

Composition
Methoxy polyethylene glycol-epoetin beta(100mcg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
August, 2025

liver
It is important to note that there is limited information on the use of Mircera 100mcg Injection in patients with liver disease. It is highly recommended to consult with your doctor for personalized guidance and advice specific to your liver condition before using this medication. Your healthcare provider will be able to assess your individual situation and provide the most appropriate recommendations to ensure your safety and well-being.

kidney
Limited information is available regarding the use of Mircera 100mcg Injection in patients with kidney disease. Please consult your doctor for guidance.

alcohol
It is advisable to consult your doctor regarding consuming alcohol with Mircera 100mcg Injection.

driving
When using Mircera 100mcg Injection, it is uncertain if driving ability is affected. Avoid driving if you have any symptoms hindering focus or reaction time.

pregnancy
Mircera 100mcg Injection may not be safe to use during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will assess benefits and risks before prescribing. Please consult your doctor regarding its use in pregnancy.

breastfeeding
During breastfeeding, caution is advised when using Mircera 100mcg Injection. It is recommended to wait until the mother's treatment is finished and the drug is cleared from her system before resuming breastfeeding.
Habit Forming | No |
Chemical Class | Carboxylic acid and derivatives |
Therapeutic Class | - |
Action Class | - |
₹10850
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025